What’s new

• GPCB issued a permanent revocation of closure directions for the Dahej plant.
• The facility was under scrutiny since February 2026 for water pollution violations.
• An interim order kept the plant running; the permanent order removes all shutdown risk.

Why it matters

This swaps a temporary stay for a permanent fix. A pharma company cannot run a global supply chain on interim protection. The resolution removes a material operational overhang.

What we’re watching

• Any changes to environmental capex or compliance spending at Piramal's other sites.
• Whether the Dahej facility's output or compliance status shifts post-resolution.
• The company's updated risk profile for its manufacturing network.

The full read

The Gujarat Pollution Control Board has permanently lifted closure directions against Piramal Pharma's Dahej facility. The site had been under scrutiny since February 2026 for potential water pollution violations, but ran continuously under an interim order. That interim protection is now replaced with a permanent resolution, eliminating the risk of a surprise operational shutdown. For a pharma company, manufacturing continuity is supply-chain continuity. The Dahej site is a major Indian production hub. The uncertainty is gone. The open question is whether this clearance changes the company's approach to environmental capital spending or compliance reporting at its other sites.

Primary source: BSE · NSE